We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
+6.69%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.1M
AUM Growth
-$6.15M
Cap. Flow
-$9.12M
Cap. Flow %
-13.8%
Top 10 Hldgs %
66.06%
Holding
59
New
15
Increased
8
Reduced
9
Closed
7

Top Buys

Rank Stock Value
1
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$7.94M
2
EWG icon
iShares MSCI Germany ETF
EWG
+$1.66M
3
BPMC
Blueprint Medicines
BPMC
+$988K
4
EWZ icon
iShares MSCI Brazil ETF
EWZ
+$935K
5
CLVS
Clovis Oncology, Inc.
CLVS
+$689K

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.8M
2
MITT
TPG Mortgage Investment Trust
MITT
+$1.21M
3
BIIB icon
Biogen
BIIB
+$1.11M
4
HEWG
iShares Currency Hedged MSCI Germany ETF
HEWG
+$1.07M
5
PMT
PennyMac Mortgage Investment
PMT
+$748K

Sector Composition

Rank Sector Weight
1 Healthcare 16.26%
2 Financials 14.74%
3 Consumer Discretionary 11.78%
4 Communication Services 8.42%
5 Real Estate 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
26
Abbott
ABT
$187B
$520K 0.79%
10,688
– –
NETI
27
DELISTED
Eneti Inc.
NETI
$513K 0.78%
7,781
+1,291
+20% +$84.6K
GREK
28
Global X MSCI Greece ETF
GREK
$316M
$506K 0.77%
+16,667
New +$458K
AERI
29
DELISTED
Aerie Pharmaceuticals
AERI
$450K 0.68%
+8,558
New +$398K
MRK icon
30
Merck
MRK
$318B
$439K 0.66%
+7,177
New +$437K
JUNO
31
DELISTED
Juno Therapeutics, Inc.
JUNO
$428K 0.65%
+14,307
New +$353K
AUPH icon
32
Aurinia Pharmaceuticals
AUPH
$2.11B
$406K 0.61%
66,304
+21,304
+47% +$144K
UA icon
33
Under Armour Class C
UA
$2.53B
$403K 0.61%
20,000
+5,000
+33% +$94.2K
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
$354K 0.54%
+6,848
New +$435K
AZN icon
35
AstraZeneca
AZN
$250B
$350K 0.53%
5,136
-1,004
-16% -$65.6K
UCP
36
DELISTED
UCP, Inc.
UCP
$343K 0.52%
31,291
-7,064
-18% -$78.2K
GDXJ icon
37
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$334K 0.51%
10,000
-9,500
-49% -$316K
EIGI
38
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$316K 0.48%
+37,847
New +$294K
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$12.4B
$311K 0.47%
+3,424
New +$312K
DHC
40
Diversified Healthcare Trust
DHC
$2.14B
$304K 0.46%
14,877
– –
GSK icon
41
GSK
GSK
$106B
$295K 0.45%
+5,480
New +$292K
GM.WS.B
42
DELISTED
General Motors Company
GM.WS.B
$292K 0.44%
16,814
– –
BLUE
43
DELISTED
bluebird bio
BLUE
$252K 0.38%
185
-54
-23% -$65.2K
VWTR
44
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$231K 0.35%
13,196
-309
-2% -$5.06K
RARE icon
45
Ultragenyx Pharmaceutical
RARE
$2.55B
$213K 0.32%
+3,424
New +$206K
PBYI icon
46
Puma Biotechnology
PBYI
$454M
$209K 0.32%
+2,393
New +$134K
GTE icon
47
Gran Tierra Energy
GTE
$317M
$103K 0.16%
4,594
– –
SAN icon
48
Banco Santander
SAN
$210B
$100K 0.15%
15,652
– –
CLF icon
49
Cleveland-Cliffs
CLF
$6.99B
$84K 0.13%
12,114
– –
MTL.PR
50
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$47K 0.07%
44,298
– –
1
2
3

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Kazazian Asset Management held 59 positions worth $66.1M, down 8.5% from $72.2M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Kazazian Asset Management withdrew a net $9.12M in Q2 2017, closing 7 positions and reducing 9 holdings. Its most notable exit was TPG Mortgage Investment Trust , an estimated $1.21M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Kazazian Asset Management opened a new position in iShares MSCI Emerging Markets ETF worth $8.07M.

  • Kazazian Asset Management's largest Q2 2017 buy was iShares MSCI Emerging Markets ETF: 195,000 shares worth $8.07M.
  • Kazazian Asset Management added most to General Motors in Q2 2017, an estimated $509K increase.
  • Kazazian Asset Management's biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.8M.
  • Kazazian Asset Management fully exited TPG Mortgage Investment Trust in Q2 2017, selling an estimated $1.21M.
  • Kazazian Asset Management's ten largest holdings make up 66% of its $66.1M portfolio in Q2 2017.
  • Kazazian Asset Management opened 15 new positions and closed 7 in Q2 2017.
  • Kazazian Asset Management's portfolio value fell 8.5% quarter-over-quarter to $66.1M.

Based on Kazazian Asset Management's 13F filing for Q2 2017, filed 14 Aug 2017.